Pathstone Holdings LLC Has $1.52 Million Position in Smith & Nephew plc (NYSE:SNN)

Pathstone Holdings LLC lifted its position in Smith & Nephew plc (NYSE:SNN) by 14.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 48,903 shares of the medical equipment provider’s stock after acquiring an additional 6,317 shares during the period. Pathstone Holdings LLC’s holdings in Smith & Nephew were worth $1,523,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Walleye Trading LLC acquired a new stake in Smith & Nephew in the first quarter worth $364,000. Boston Partners bought a new position in Smith & Nephew during the first quarter worth about $2,524,000. Mather Group LLC. lifted its holdings in Smith & Nephew by 9,735.3% during the second quarter. Mather Group LLC. now owns 1,672 shares of the medical equipment provider’s stock worth $42,000 after acquiring an additional 1,655 shares in the last quarter. Simplicity Wealth LLC grew its stake in Smith & Nephew by 13.4% in the second quarter. Simplicity Wealth LLC now owns 16,848 shares of the medical equipment provider’s stock valued at $417,000 after acquiring an additional 1,993 shares during the period. Finally, Opal Wealth Advisors LLC bought a new stake in shares of Smith & Nephew in the second quarter worth about $101,000. Institutional investors own 25.64% of the company’s stock.

Smith & Nephew Price Performance

SNN stock opened at $25.71 on Friday. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63. Smith & Nephew plc has a fifty-two week low of $23.65 and a fifty-two week high of $31.72. The business has a 50-day moving average of $27.67 and a 200-day moving average of $27.87.

Analyst Ratings Changes

Several research firms have recently weighed in on SNN. StockNews.com cut Smith & Nephew from a “strong-buy” rating to a “buy” rating in a report on Tuesday, November 12th. Deutsche Bank Aktiengesellschaft cut shares of Smith & Nephew from a “buy” rating to a “hold” rating in a report on Friday, November 1st. Finally, Berenberg Bank lowered shares of Smith & Nephew from a “buy” rating to a “hold” rating in a report on Wednesday, November 6th.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.